Organization
Universitätsklinikum Hamburg-Eppendorf
18 clinical trials
2 abstracts
Abstract
Results of a tailored multimodal lifestyle follow-up care program focusing on physical activity, nutritional behavior and psychological processes in adolescent and young adult cancer survivors: The CARE for CAYA multicenter, randomized clinical trial.Org: University Cancer Center Hamburg, Universitätsklinikum Hamburg-Eppendorf, University Hospital Bonn, Department of Internal Medicine I, Medical University of Vienna, Campus Luebeck,
Clinical trial
A Randomized Multi-Center Treatment Study (COALL 08-09) to Improve the Survival of Children With Acute Lymphoblastic Leukemia on Behalf of the German Society of Pediatric Hematology and OncologyStatus: Active (not recruiting), Estimated PCD: 2019-12-01
Clinical trial
Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality - FAIR-HF2Status: Completed, Estimated PCD: 2024-05-02
Clinical trial
Combined N-of-1 Trials to Assess Open-Label Placebo Treatment for Antidepressant Discontinuation SymptomsStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line TherapyStatus: Recruiting, Estimated PCD: 2028-03-01
Clinical trial
Disentangling Pharmacological and Expectation Effects in Antidepressant Discontinuation - a Randomized, Balanced Open-hidden TrialStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Phase II Multicenter Study of Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host DiseaseStatus: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
TherVacB_Phase1a: Open Phase 1a Trial to Assess the Safety and Immunogenicity of a Heterologous Protein Prime/MVA Boost Therapeutic Hepatitis B Vaccine Candidate in Healthy VolunteersStatus: Recruiting, Estimated PCD: 2025-02-01
Clinical trial
Durability of Immunity Induced by the Ebolavirus Vaccine VSV-EBOV and As-sessment of a Booster Dose for Pre-Exposure Prophylaxis in Individuals at Potential Occupational Risk for Ebolavirus ExposureStatus: Not yet recruiting, Estimated PCD: 2026-03-01
Clinical trial
Multicenter, Randomized, Double-blind, Biomarker-guided, Phase II Trial With Adrecizumab (HAM 8101) to Improve proGNosis and outcomES in Patients With Moderate to Severe COVID-19Status: Terminated, Estimated PCD: 2023-08-25
Clinical trial
A Two-center, Randomized, Double-blind, Placebo-controlled, Phase Ib Study to Assess the Safety, Tolerability and Immunogenicity of Two Ascending Doses of the Candidate Vaccine MVA-MERS-S_DF-1 in Healthy Study SubjectsStatus: Active (not recruiting), Estimated PCD: 2022-11-28
Clinical trial
Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Cholangiocarcinoma and Muscle Invasive Gall Bladder Carcinoma (ACTICCA-1 Trial)Status: Active (not recruiting), Estimated PCD: 2024-04-01
Clinical trial
A Multi-center, Randomized Placebo-controlled Phase II Trial to Assess the Safety, Tolerability and Immunogenicity of Two Doses of the Candidate Vaccine MVA-SARS-2-S in Adults Aged 18 to 64 and 65 and OlderStatus: Withdrawn, Estimated PCD: 2022-11-02
Clinical trial
Combination Treatment of Belantamab Mafodotin and Venetoclax in Treatment of Relapsed and Refractory t(11;14) Multiple Myeloma (Phase I/IIa) The BELI(E)VE-TrialStatus: Recruiting, Estimated PCD: 2026-11-01
Clinical trial
Clinical Phase II, Multicenter, Open-label Study Evaluating iNduction, Consolidation and Maintenance With Isatuximab (SAR650984), Carfilzomib, LEnalidomide and Dexamethasone (I-KRd) in Primary Diagnosed High-risk Multiple Myeloma paTientsStatus: Active (not recruiting), Estimated PCD: 2026-05-01
Clinical trial
Hamburg Edoxaban for Anticoagulation in COVID-19 StudyStatus: Completed, Estimated PCD: 2022-09-06
Clinical trial
Comparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Versus Primary Radiochemotherapy for Oropharyngeal CancerStatus: Active (not recruiting), Estimated PCD: 2024-05-05
Clinical trial
Multicenter Randomized Controlled Phase III Study of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant TherapyStatus: Active (not recruiting), Estimated PCD: 2024-05-01
Clinical trial
Evaluating Trifluridine/Tipiracil Based Chemoradiation in Locally Advanced Rectal Cancer - The Phase I/II TARC TrialStatus: Terminated, Estimated PCD: 2022-09-02
Abstract
Uterine sarcoma patients who underwent morcellation: Who are they? Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA- NOGGO RU1).Org: Charité - Universitätsmedizin Berlin, Berlin, Germany, Helios Klinikum Berlin-Buch, Kliniken Essen-Mitte, Evangelische Huyssens-Stiftung/Knappschaft GmbH, Tuebingen University Hospital,